Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Acta Pharmacol Sin ; 43(10): 2687-2695, 2022 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-35296779

RESUMO

The small molecule chemical compound cinobufotalin (CB) is reported to be a potential antitumour drug that increases cisplatin (DDP) sensitivity in nasopharyngeal carcinoma. In this study, we first found that CB decreased DDP resistance, migration and invasion in lung adenocarcinoma (LUAD). Mechanistic studies showed that CB induced ENKUR expression by suppressing PI3K/AKT signalling to downregulate c-Jun, a negative transcription factor of ENKUR. Furthermore, ENKUR was shown to function as a tumour suppressor by binding to ß-catenin to decrease c-Jun expression, thus suppressing MYH9 transcription. Interestingly, MYH9 is a binding protein of ENKUR. The Enkurin domain of ENKUR binds to MYH9, and the Myosin_tail of MYH9 binds to ENKUR. Downregulation of MYH9 reduced the recruitment of the deubiquitinase USP7, leading to increased c-Myc ubiquitination and degradation, decreased c-Myc nuclear translocation, and inactivation of epithelial-mesenchymal transition (EMT) signalling, thus attenuating DDP resistance. Our data demonstrated that CB is a promising antitumour drug and may be a candidate chemotherapeutic drug for LUAD patients.


Assuntos
Adenocarcinoma de Pulmão , Antineoplásicos , Cisplatino , Neoplasias Nasofaríngeas , Proteínas Adaptadoras de Transdução de Sinal , Adenocarcinoma de Pulmão/tratamento farmacológico , Antineoplásicos/farmacologia , Antineoplásicos/uso terapêutico , Bufanolídeos , Proteínas de Ligação a Calmodulina , Linhagem Celular Tumoral , Cisplatino/farmacologia , Cisplatino/uso terapêutico , Resistencia a Medicamentos Antineoplásicos , Regulação Neoplásica da Expressão Gênica , Humanos , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/patologia , Cadeias Pesadas de Miosina , Miosinas/metabolismo , Neoplasias Nasofaríngeas/tratamento farmacológico , Fosfatidilinositol 3-Quinases/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Fatores de Transcrição/metabolismo , Peptidase 7 Específica de Ubiquitina , beta Catenina/metabolismo
2.
Beilstein J Org Chem ; 8: 344-8, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22509203

RESUMO

A novel and reliable method for the direct preparation of 2,2-dihalo-N-phenylacetamides is reported. The key transformation involves the cleavage of a carbon-carbon bond in the presence of DIB and a Lewis acid as the halogen source, and thus this method significantly expands the value of DIB as a unique and powerful tool in chemical synthesis. This protocol not only adds a new aspect to reactions that use other hypervalent iodine reagents but also provides a wide space for the synthesis of disubstituted acetamides.

3.
Beilstein J Org Chem ; 7: 1436-40, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22049301

RESUMO

1-Carbamoyl-2-oxopropyl acetate derivatives were synthesized through an acetoxylation process to methylene with the aid of (diacetoxyiodo)benzene (DIB) as the oxidant. Not only mild reaction conditions, but also excellent yields and good substrate scope make the present protocol potentially useful in organic synthesis.

4.
Acta Crystallogr Sect E Struct Rep Online ; 65(Pt 6): m682, 2009 May 23.
Artigo em Inglês | MEDLINE | ID: mdl-21583041

RESUMO

In the title complex, [La(C(6)H(4)NO(3))(C(2)O(4))(H(2)O)(2)](n), the La(III) ion is coordinated by eight O atoms from two 2-oxido-pyridinium-3-carboxyl-ate ligands, two oxalate ligands and two water mol-ecules in a distorted bicapped square-anti-prismatic geometry. The carboxyl-ate groups link adjacent La(III) ions, forming two-dimensional layers that are further linked by N-H⋯O and O-H⋯O hydrogen bonds.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA